Baidu
map

Food Nutr Res:伊贝母总生物碱提取物对香烟烟雾致Beas-2B细胞损伤模型的保护作用及转录组学分析

2024-07-10 紫菀款冬 MedSci原创 发表于上海

该研究探讨伊贝母(BFP)总生物碱提取物(BFP-TA)对香烟烟雾提取物(CSE)诱导的Beas-2B细胞损伤的作用及机制。

背景:慢性阻塞性肺病(COPD)是一种慢性进行性气道和肺部疾病,患病率和死亡率都很高,而且患病率随着年龄的增长而增加。据世界卫生组织预测,到2030年,慢性阻塞性肺病预计将成为全球第三大死亡原因。目前的药物治疗对COPD的进展或死亡率影响有限,而且几乎没有证据表明任何一种药物具有逆转气道重塑和气流阻塞的潜力。因此,迫切需要开发安全有效的COPD治疗新药。

伊贝母(BFP)是一种长期用于治疗肺部疾病的中药,具有润肺、化痰、止咳、抗炎、抗氧化等功效,但其有效成分和作用机制尚不清楚。

目的:探讨BFP总生物碱提取物(BFP-TA)香烟烟雾提取物(CSE)诱导的Beas-2B细胞损伤的作用及机制。

方法:用2% CSE诱导Beas-2B细胞损伤模型,按照T-AOC检测试剂盒、SOD检测试剂盒和MDA检测试剂盒的说明检测BFP-TA对细胞总抗氧化能力(T-AOC)、超氧化物歧化酶(SOD)和丙二醛(MDA)水平的影响,荧光显微镜下检测ROS的产生。流式细胞术检测BFP-TA对Beas-2B细胞凋亡的影响,western blot检测BFP-TA对相关蛋白表达的影响。

随后,通过转录组测序研究了BFP-TA对CSE诱导的Beas-2B细胞中差异表达基因(DEGs)的影响,并通过定量实时聚合酶链反应(qPCR)验证了DEGs的表达。

结果:BFP-TA通过提高T-AOC和SOD水平,抑制ROS和MDA水平,减轻CSE诱导的Beas-2B细胞氧化损伤,其机制可能与SIRT1/Nrf2/Keap1信号通路有关。此外,BFP-TA可以通过抑制Bax、MST1和FOXO3a蛋白的表达来抑制CSE诱导的细胞凋亡,并通过抑制MAPK信号通路的激活来发挥抗炎作用

随后,转录组分析和qPCR验证表明,BFP-TA通过调节PPAR和PI3K-Akt信号通路中DEGs的表达,减轻炎症、氧化应激、细胞凋亡和脂质代谢紊乱,从而对CSE诱导的Beas-2B细胞损伤起到保护作用

结论:该研究首次证实BFP-TA可通过抗炎、抗氧化、抗凋亡、调节脂质代谢紊乱等作用对CSE诱导的Beas-2B细胞损伤起到保护作用。

原始出处:

Wang X, Liu X, Aga EB, Tse WM, Tse KWG, Ye B. Protective effect of the total alkaloid extract from Bulbus Fritillariae Pallidiflorae on cigarette smoke-induced Beas-2B cell injury model and transcriptomic analysis. Food Nutr Res. 2024;68:10.29219/fnr.v68.10689. Published 2024 Jun 11. doi:10.29219/fnr.v68.10689

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2214314, encodeId=6fea2214314a9, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Wed Jul 10 21:21:34 CST 2024, time=2024-07-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214313, encodeId=651f221431392, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/23/914ab8c212b86139546fc16eed98b36f.jpg, createdBy=90821711402, createdName=1dea4a7em68(暂无匿称), createdTime=Wed Jul 10 20:56:55 CST 2024, time=2024-07-10, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2214317, encodeId=8217221431ea4, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Wed Jul 10 21:32:03 CST 2024, time=2024-07-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2214346, encodeId=30a522143463c, content=感谢您的分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/dc7b735700e1458a81dbbd2418ed68be-WBVuUZqXzOAb.jpg, createdBy=c6d55463285, createdName=Dew·, createdTime=Thu Jul 11 00:17:50 CST 2024, time=2024-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2214292, encodeId=24c12214292eb, content=#COPD# #转录组学# #Beas-2B细胞# # 伊贝母# #香烟烟雾提取物# #总生物碱#, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Wed Jul 10 18:09:23 CST 2024, time=2024-07-10, status=1, ipAttribution=上海)]
    2024-07-10 yangchou 来自浙江省

    好文章,谢谢分享。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2214314, encodeId=6fea2214314a9, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Wed Jul 10 21:21:34 CST 2024, time=2024-07-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214313, encodeId=651f221431392, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/23/914ab8c212b86139546fc16eed98b36f.jpg, createdBy=90821711402, createdName=1dea4a7em68(暂无匿称), createdTime=Wed Jul 10 20:56:55 CST 2024, time=2024-07-10, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2214317, encodeId=8217221431ea4, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Wed Jul 10 21:32:03 CST 2024, time=2024-07-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2214346, encodeId=30a522143463c, content=感谢您的分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/dc7b735700e1458a81dbbd2418ed68be-WBVuUZqXzOAb.jpg, createdBy=c6d55463285, createdName=Dew·, createdTime=Thu Jul 11 00:17:50 CST 2024, time=2024-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2214292, encodeId=24c12214292eb, content=#COPD# #转录组学# #Beas-2B细胞# # 伊贝母# #香烟烟雾提取物# #总生物碱#, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Wed Jul 10 18:09:23 CST 2024, time=2024-07-10, status=1, ipAttribution=上海)]
    2024-07-10 1dea4a7em68(暂无匿称) 来自福建省

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2214314, encodeId=6fea2214314a9, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Wed Jul 10 21:21:34 CST 2024, time=2024-07-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214313, encodeId=651f221431392, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/23/914ab8c212b86139546fc16eed98b36f.jpg, createdBy=90821711402, createdName=1dea4a7em68(暂无匿称), createdTime=Wed Jul 10 20:56:55 CST 2024, time=2024-07-10, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2214317, encodeId=8217221431ea4, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Wed Jul 10 21:32:03 CST 2024, time=2024-07-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2214346, encodeId=30a522143463c, content=感谢您的分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/dc7b735700e1458a81dbbd2418ed68be-WBVuUZqXzOAb.jpg, createdBy=c6d55463285, createdName=Dew·, createdTime=Thu Jul 11 00:17:50 CST 2024, time=2024-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2214292, encodeId=24c12214292eb, content=#COPD# #转录组学# #Beas-2B细胞# # 伊贝母# #香烟烟雾提取物# #总生物碱#, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Wed Jul 10 18:09:23 CST 2024, time=2024-07-10, status=1, ipAttribution=上海)]
    2024-07-10 医鸣惊人 来自山西省

    认真学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2214314, encodeId=6fea2214314a9, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Wed Jul 10 21:21:34 CST 2024, time=2024-07-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214313, encodeId=651f221431392, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/23/914ab8c212b86139546fc16eed98b36f.jpg, createdBy=90821711402, createdName=1dea4a7em68(暂无匿称), createdTime=Wed Jul 10 20:56:55 CST 2024, time=2024-07-10, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2214317, encodeId=8217221431ea4, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Wed Jul 10 21:32:03 CST 2024, time=2024-07-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2214346, encodeId=30a522143463c, content=感谢您的分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/dc7b735700e1458a81dbbd2418ed68be-WBVuUZqXzOAb.jpg, createdBy=c6d55463285, createdName=Dew·, createdTime=Thu Jul 11 00:17:50 CST 2024, time=2024-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2214292, encodeId=24c12214292eb, content=#COPD# #转录组学# #Beas-2B细胞# # 伊贝母# #香烟烟雾提取物# #总生物碱#, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Wed Jul 10 18:09:23 CST 2024, time=2024-07-10, status=1, ipAttribution=上海)]
    2024-07-11 Dew·

    感谢您的分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2214314, encodeId=6fea2214314a9, content=好文章,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Wed Jul 10 21:21:34 CST 2024, time=2024-07-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2214313, encodeId=651f221431392, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/23/914ab8c212b86139546fc16eed98b36f.jpg, createdBy=90821711402, createdName=1dea4a7em68(暂无匿称), createdTime=Wed Jul 10 20:56:55 CST 2024, time=2024-07-10, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2214317, encodeId=8217221431ea4, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Wed Jul 10 21:32:03 CST 2024, time=2024-07-10, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2214346, encodeId=30a522143463c, content=感谢您的分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/dc7b735700e1458a81dbbd2418ed68be-WBVuUZqXzOAb.jpg, createdBy=c6d55463285, createdName=Dew·, createdTime=Thu Jul 11 00:17:50 CST 2024, time=2024-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2214292, encodeId=24c12214292eb, content=#COPD# #转录组学# #Beas-2B细胞# # 伊贝母# #香烟烟雾提取物# #总生物碱#, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Wed Jul 10 18:09:23 CST 2024, time=2024-07-10, status=1, ipAttribution=上海)]
    2024-07-10 梅斯管理员 来自上海

    #COPD# #转录组学# #Beas-2B细胞# # 伊贝母# #香烟烟雾提取物# #总生物碱#

    0

相关资讯

Front Immunol:综合代谢组学和脂质组学特征辨证慢性阻塞性肺疾病的中医证型

结合代谢组学和脂质组学,表征健康受试者与COPD不同中医证型的代谢标志物。

ERJ:与COPD相关的严重肺动脉高压低氧血症的机制

在通过利用多重惰性气体消除技术(MIGET)评估通气-灌注(VA/Q)关系,分析与COPD相关的严重PH患者低氧血症的决定因素。

走出COPD新药研发“死亡谷”:赛诺菲解锁炎症性疾病新“地图”

作为COPD领域即将迎来的第一款生物制剂,度普利尤单抗也即将开创COPD治疗新纪元,为仅有“对症治疗”方法的患者提供全新的治疗选择。从特应性皮炎到COPD,度普利尤单抗的临床价值被充分挖掘。

J Ethnopharmacol:结合网络药理学和药理学研究探讨定喘汤抗慢性阻塞性肺疾病的潜在机制

探讨定喘汤(DCT)在体内和体外治疗慢性阻塞性肺疾病(COPD)的疗效,并阐明其抗COPD的可能机制。

肺康复:回顾与展望

肺康复(PR)是一种针对慢性肺病患者的全面管理方法,包括运动、教育和心理社会支持。

过多的氧气对COPD患者不利?

人体的重要器官在低氧环境下是难以承受的,而这种治疗策略(即因担心二氧化碳浓度升高而不给慢性阻塞性肺病患者吸氧)对患者来说基本上是致命的,对被误导的医生来说则是职业生涯的悲剧。

Academic radiology:CT放射组学特征在慢性阻塞性肺病患者中的应用

基于纹理的放射组学特征可以从CT图像中提取的定量特征,为临床提供关于体素灰度的相关信息。

通过无创通气降低 PCO2 与改善慢性高碳酸血症呼吸衰竭患者的生存率相关

接受无创通气治疗的慢性高碳酸血症受试者的 PCO2 相对基线的降低与生存率的提高相关。管理策略应以最大程度地减少 PCO2 为目标。

NEJM:度普利尤单抗治疗COPD伴血液嗜酸性粒细胞显示2型炎症患者

鉴于炎症对COPD发病机制的重要性,寻找靶向免疫/炎症通路的药物一直是该疾病药物研发的重点。与近年来免疫/炎症通路其他适应症(如哮喘、类风湿性关节炎和炎症性肠病等)单克隆抗体药物开发屡屡成功形成鲜明对

FDA批准PDE3/4抑制剂ensifentrine用于成人COPD的维持治疗,这是首个吸入式疗法

慢性阻塞性肺病是一种进行性疾病,可引起肺部气流阻塞,导致呼吸困难。它影响全球大约3.84亿人,是全球第三大死亡原因。改善肺功能,减少急性加重和管理日常症状是此疾病管理中的重要治疗目标。即使是单次急性加

Baidu
map
Baidu
map
Baidu
map